Laying Out Strategic & Technical Perspectives to Implement AI to Support & Improve Drug Discovery & Research Workflows

• Contextualizing pharma’s attitude to “lock and key” drug discovery hurdles, and how to best perform biological validation of target protein over designing better drugs
• Applying AI tools across multi-omics data and alternative experimental design to investigate the causal impact of drugging target proteins
• Assessing the reliability of AI within target protein validation to maximize the success rate of drugs in the clinic at the discovery stage

Speakers:

Daniel Dai

Scientific Manager

Sanofi